http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2583435-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5990487ffa0df1554b0d62a697f7b42e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3eb4ff26047c4a0e39dfe9a50becbda http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_925b7432670fe359e0a519a7475daa70 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-56 |
| filingDate | 2011-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d7d2e78ef69bdba79c5f1faf4f5f39d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac6697755d7f5a541fc8a6e00abe4929 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf661580c4f18544ad0c08f521612543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09abe5ee20b458baa85f8e7367dec0dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c134d0bc1035a338841db69863cd1316 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e13cc29df550f79839aa3526c5d03be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f134da0a2feba658a85b4d88ffbaa3b |
| publicationDate | 2016-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2583435-C2 |
| titleOfInvention | Peripherally restricted faah inhibitors |
| abstract | FIELD: chemistry. n SUBSTANCE: invention relates to a compound of formula (1) n n n n where R 1 is selected from the group consisting of a hydroxy group and physiologically hydrolysable esters thereof and -NR 8 R 9 , where R 8 and R 9 are independently selected from the group consisting of hydrogen and unsubstituted (C 1 -C 3 )alkyl; R 2 and R 3 are independently selected from the group consisting of hydrogen or unsubstituted (C 1 -C 3 )alkyl; each R 4 is independently selected from the group consisting of halogen and unsubstituted (C 1 -C 3 )alkyl, and n is an integer from 0 to 4; each R 5 is independently selected from the group consisting of halogen and unsubstituted (C 1 -C 3 )alkyl, and m is an integer from 0 to 3; R 6 is unsubstituted cyclohexyl or cyclohexyl substituted with (C 1 -C 6 )alkyl, halogen or trifluoromethyl; and pharmaceutically acceptable salts thereof. The compounds are intended for producing a pharmaceutical composition or a medicinal agent for inhibiting FAAH in a mammal in need thereof, where the mammal needs treatment of pain, an inflammatory disorder or treatment for accelerated wound healing. The compounds are also intended for raising the peripheral level of anandamide, oleoylethanolamide (OEA), palmitoylethanolamide (PEA) or stearoylethanolamide (SEA) in a mammal in need thereof. n EFFECT: peripherally restricted FAAH inhibitors. n 28 cl, 2 tbl, 29 dwg |
| priorityDate | 2010-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 156.